The Syrian government recently approved a 30 percent increase in the prices of locally produced medicines in a concession to manufacturers who have threatened to halt production since the deterioration of the Syrian pound has decimated their profits.

The Syrian Insurance Company (SIC), the country’s largest and only state-owned insurer, says it has contracted with the Ministry of Defence to provide services for its clients at the ministry’s hospitals, in a new sign of the growing reach and influence of military-run companies.


The Ministry of Health has cancelled the licence of ten new pharmaceutical companies despite the fact that some of them were near completion and set to start production.


Britain’s GlaxoSmithKline, one of the world’s largest drug manufacturers, and its local distributor, Unipharma, face allegations of corruption in their Syrian operations.